chr10-73139424-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_007265.3(ECD):āc.1306T>Cā(p.Ser436Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000113 in 1,614,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_007265.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ECD | NM_007265.3 | c.1306T>C | p.Ser436Pro | missense_variant | 11/14 | ENST00000372979.9 | NP_009196.1 | |
ECD | NM_001135752.1 | c.1405T>C | p.Ser469Pro | missense_variant | 12/15 | NP_001129224.1 | ||
ECD | NM_001135753.1 | c.1177T>C | p.Ser393Pro | missense_variant | 10/13 | NP_001129225.1 | ||
ECD | NR_024203.1 | n.1138T>C | non_coding_transcript_exon_variant | 9/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ECD | ENST00000372979.9 | c.1306T>C | p.Ser436Pro | missense_variant | 11/14 | 1 | NM_007265.3 | ENSP00000362070.4 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152172Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251466Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135904
GnomAD4 exome AF: 0.0000978 AC: 143AN: 1461866Hom.: 0 Cov.: 33 AF XY: 0.000110 AC XY: 80AN XY: 727228
GnomAD4 genome AF: 0.000263 AC: 40AN: 152172Hom.: 0 Cov.: 31 AF XY: 0.000336 AC XY: 25AN XY: 74336
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at